WHO chief praises Guineans for help with Ebola vaccine

May 4, 2017

The head of the World Health Organization is praising Guineans for their role in helping to develop a vaccine against the deadly Ebola virus.

On a visit to the country where the world's deadliest Ebola outbreak emerged in 2013, Dr. Margaret Chan said Guineans had "fought back" by helping scientists.

There is no licensed treatment for Ebola, and the outbreak killed more than 11,300 people. Researchers began testing the vaccine as the outbreak was waning.

WHO, which has acknowledged shortcomings in its response to the Ebola outbreak in West Africa, led the study of the vaccine.

The vaccine was developed by the Canadian government and is now licensed to the U.S.-based Merck & Co.

Chan says the 's impact will be significant even if supplies initially are limited.

Explore further: Ebola vaccine shows 'promising' results: WHO

Related Stories

Ebola vaccine shows 'promising' results: WHO

July 31, 2015
Preliminary results of tests on an Ebola vaccine to be published later Friday in British science magazine The Lancet have shown "promising" results, World Health Organization Director-General Margaret Chan said.

Johnson & Johnson starts Ebola vaccine trial in Sierra Leone

October 9, 2015
Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone.

Russia says its Ebola vaccine 'effective' in initial tests

February 15, 2016
Russia's health minister said Monday that an Ebola vaccine developed by the country over the last 15 months had shown encouraging results and would undergo further testing in West Africa.

Global Vaccine promises $5 million to develop Ebola vaccine

January 20, 2016
The global vaccine alliance GAVI says it will donate $5 million toward developing the leading Ebola vaccine, hoping that it will be approved by a regulator by the end of 2017.

Ebola vaccine trial begins in Sierra Leone

April 14, 2015
Thousands of healthcare workers in areas of Sierra Leone that are grappling with Ebola will now begin receiving an experimental vaccine against the often deadly virus, officials said Tuesday.

WHO yet to take Canada's experimental Ebola vaccine

October 9, 2014
Doses of a prototype Ebola vaccine developed by Canada remain in the country even though they were offered to the World Health Organization nearly two months ago, the health minister said Thursday.

Recommended for you

Anxious women may want to keep an eye on their bone health

May 18, 2018
(HealthDay)—As if older women didn't already worry enough about their bone health, new research suggests that anxiety may up their risk for fractures.

FDA approves first drug aimed at preventing migraines

May 18, 2018
(HealthDay)—The millions of Americans who suffer from migraine may have a new source of hope—the first drug aimed at preventing the headaches gained U.S. Food and Drug Administration approval on Thursday.

New strategy to cure chronic hepatitis B infection

May 18, 2018
Scientists from Karolinska Institutet and Hannover Medical School have published two studies that provide insights into how the immune system responds and helps to clear a hepatitis B infection after treatment interruption. ...

Resistance to antifungal drugs could lead to disease and global food shortages

May 17, 2018
Growing levels of resistance to antifungal treatments could lead to increased disease outbreaks and affect food security around the world.

Pig immunology comes of age: Killer T cell responses to influenza

May 17, 2018
Researchers from The Pirbright Institute, University of Bristol, Cardiff University and University of Oxford have generated tools that allow scientists to understand a vital area of the pig immune system which was previously ...

How intestinal worms hinder tuberculosis vaccination

May 17, 2018
New research in mice suggests that chronic infection with intestinal worms indirectly reduces the number of cells in lymph nodes near the skin, inhibiting the immune system's response to the Bacille Calmette-Guerin (BCG) ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.